760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
ID: 36C77025Q0079Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/1dcd63267b5641e99c0c9388ce147548/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.

    Point(s) of Contact
    Jennifer L Knight
    (913) 684-0162
    jennifer.knight@va.gov
    Files
    Title
    Posted
    S02_JnA_Q0079_allsigned.pdf
    The Department of Veterans Affairs is seeking to procure five specific brand name pharmaceuticals for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under the Simplified Acquisition Procedures outlined in FAR 13.5. The justification for sole-source procurement highlights that only the unique products can fulfill the requirements established by physician prescriptions, with no substitutions permitted due to clinical evaluations by Pharmacy Benefits Management (PBM). The procurement will be a firm-fixed-price contract, with delivery expected within ten days after receipt of order. Market research, conducted to assess available sources, confirmed that Abbvie, the original equipment manufacturer (OEM) of the specified products, does not have registered small business distributors that meet the necessary criteria under the Non-Manufacturer Rule. Consequently, competition is restricted as no other suppliers can provide the required pharmaceuticals, aligning with regulatory provisions. Although previous contracts involved both large and small businesses, only qualified vendors complying with Drug Supply Chain Security Act requirements will be solicited. The anticipated cost is expected to be fair based on historical data and market evaluations, ensuring compliance with procurement guidelines. Overall, this acquisition underlines the VA's commitment to providing specific medications to veterans while adhering to regulatory and market procedures.
    S02_Pre_Sol_36C77025Q0079_final_.pdf
    The Department of Veterans Affairs is issuing a presolicitation notice for the procurement of Armour Thyroid tablets for the Leavenworth CMOP facility, located at 5000 S. 13th Street, Leavenworth, Kansas. The solicitation number for this request is 36C77025Q0079, with bids due by December 27, 2024, at 4 PM Central Time. This contract is classified under the product service code 6505 (Drug and Biologicals) and the NAICS code 325412 (Pharmaceutical Preparation Manufacturing). A total of five different Armour Thyroid tablet variants, ranging from 30-180mg, are required in specific quantities and packaging configurations. Vendors must be registered in SAM.gov and submit their proposals via email, including essential documentation such as the signed SF1449 solicitation cover page, pricing schedule, applicable licenses, and a Buy American Act Certificate if necessary. Timely and compliant submissions are critical, as incomplete packages will be rejected. This effort underscores the VA’s commitment to ensuring a stable supply of essential medications for veterans' care while promoting compliance with federal regulations.
    S02_Pricing Schedule_Q0079.xlsx
    The document pertains to a Request for Quotation (RFQ) for pharmaceutical supplies from the Leavenworth CMOP, with a specific focus on the procurement of various dosages of Armour Thyroid tablets. The RFQ identifies necessary documentation, including a signed solicitation cover page (SF1449), a quote spreadsheet, and compliance with the Buy American Act (BAA). Vendors must submit their quotes by December 27, 2024, by 4:00 PM CST, with a requirement for only one submission per vendor. Key products listed include multiple strengths of Armour Thyroid tablets, with specific quantities requested. Each submission must detail unit pricing, total pricing, and product expiration dates, ensuring a minimum shelf life of one year from delivery. Additional requirements include a state wholesale distributor license, and if applicable, a subcontracting plan. This RFQ reflects government efforts to secure essential pharmaceuticals, ensuring compliance with federal regulations and prioritizing quality supply chains for healthcare provisions. Overall, it serves the objective of facilitating a streamlined procurement process while adhering to regulatory stipulations.
    S02_RFQ_36C77025Q0079_.pdf
    The document outlines a federal Request for Proposal (RFP) from the Department of Veterans Affairs (VA), specifically for the acquisition of pharmaceutical products for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP). It specifies that the solicitation (number 36C77025Q0079) is open to all businesses, but emphasizes a goal for small business participation. The RFP includes instructions for submissions, including the requirement for a signed Standard Form 1449 and an Excel pricing schedule. Key components of the RFP involve detailing the specific pharmaceutical items requested, delivery schedules, and adherence to labeling standards such as bar coding requirements compliant with industry regulations. Additionally, it establishes conditions regarding recalls, product quality, and compliance with the Drug Supply Chain Security Act. The RFP is meticulously structured, including sections on general terms and conditions, price/cost schedules, and delivery expectations. The document stresses the importance of compliance with various federal regulations, including FAR and VAAR clauses. This procurement process exemplifies the government's commitment to sourcing pharmaceutical supplies while promoting transparency, process adherence, and support for small businesses within the federal contracting framework.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0117 770-25-2-0182 - National CMOP T0224 TERBINAFINE HCL 1% CREAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Terbinafine HCL 1% Cream for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities across multiple locations. This acquisition, identified by solicitation number 36C77025Q0117, is set aside for small businesses and requires vendors to provide specific documentation, including a completed price schedule in Excel format and a state wholesale distributor license, to ensure compliance with the Drug Supply Chain Security Act. The timely delivery of these pharmaceuticals is crucial for maintaining a reliable supply for veterans, with a delivery timeframe of 10 days after receipt of order and shipments directed to seven designated CMOP locations. Interested vendors must submit their quotes by January 23, 2025, with an estimated award date of January 28, 2025; for further inquiries, contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--Domestic Pharmaceuticals/Med/Surge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    6505--Metformin SA Tablets REPACK PROGRAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Metformin SA Tablets through a repack program, as outlined in solicitation 36E79725R0003. Bidders are required to meet specific packaging standards, including the use of safety-caps that can be converted or deshelled, with bottles having a minimum size of 120cc and a cylindrical design that accommodates a label of specified dimensions. This procurement is critical for ensuring the availability of essential pharmaceutical products for veteran populations, adhering to FDA regulations and maintaining healthcare quality. Interested parties must submit their offers by January 28, 2025, at 2:30 PM CST, and can direct inquiries to Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to supply Cyclobenzaprine HCL Tablets under solicitation number VA-25-00015093. The procurement involves providing pharmaceutical supplies over a base year and four option years, with specific requirements for submission formats, safety protocols, and compliance with drug supply chain security standards. Cyclobenzaprine is a critical medication used for muscle relaxation, making this procurement essential for ensuring consistent availability for veterans and healthcare facilities. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details regarding the submission process and compliance requirements.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    6505--Radiopharmaceuticals Renew Period: 2-1-2025-01/31/2028
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide radiopharmaceuticals for the Jesse Brown VA Medical Center in Chicago, Illinois, under a Firm-Fixed Price Indefinite Delivery Indefinite Quantity (IDIQ) contract. The procurement encompasses a range of radioactive medical supplies, including Thallium-201 chloride, I-123 and I-131 capsules, and Tc-99m compounds, with specific dosages and estimated quantities outlined for the ordering period from February 1, 2025, to January 31, 2028. These radiopharmaceuticals are critical for diagnostic and therapeutic procedures in nuclear medicine, ensuring effective healthcare services for veterans. Interested parties should contact Contract Specialist Steven MacDonald at steven.macdonald@va.gov or 414-844-4882 for further details and to ensure compliance with the VA’s procurement standards.
    6505--Nadolol Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Nadolol tablets as part of its Pharmaceutical Prime Vendor Program. This solicitation requires bidders to provide various dosages of Nadolol, along with unique National Drug Codes (NDCs), and to adhere to strict compliance with federal manufacturing practices and regulations, including the Drug Supply Chain Security Act. The consistent supply of these pharmaceuticals is crucial for meeting the healthcare needs of veterans, ensuring they receive necessary medications without interruption. Interested parties should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must adhere to the submission requirements outlined in the solicitation document, which includes a 0.5% cost recovery fee and specific timelines for bid submission.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.